Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients

Blood Cancer Journal, Published online: 04 November 2020; doi:10.1038/s41408-020-00374-3Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients

Source: Blood Cancer Journal - November 4, 2020 Category: Hematology Authors: S. Thiant M. M. Moutuou P. Laflamme R. Sidi Boumedine D. M. Leboeuf L. Busque J. Roy M. Guimond Source Type: research